Literature DB >> 2938725

Antipromotional activity of dietary N-(4-hydroxyphenyl)retinamide in two-stage skin tumorigenesis in CD-1 and SENCAR mice.

D L McCormick, R C Moon.   

Abstract

The activity of the synthetic retinoid, N-(4-hydroxyphenyl)retinamide (4-HPR), as a promoter and as an inhibitor of tumor promotion in mouse skin was investigated using CD-1 and SENCAR mice. Dietary administration of 4-HPR inhibited skin tumor promotion by 12-O-tetradecanoylphorbol-13-acetate (TPA) in both mouse strains, although protective activity was observed only at high TPA doses. Dietary 4-HPR had no promoting activity in mice receiving initiation and no TPA promotion. These data suggest that retinoid promotion of skin tumorigenesis may be specific to retinoic acid, and is not necessarily characteristic of the entire chemical class.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 2938725     DOI: 10.1016/0304-3835(86)90003-0

Source DB:  PubMed          Journal:  Cancer Lett        ISSN: 0304-3835            Impact factor:   8.679


  9 in total

Review 1.  Retinoid pathway and cancer therapeutics.

Authors:  Nathan Bushue; Yu-Jui Yvonne Wan
Journal:  Adv Drug Deliv Rev       Date:  2010-08-03       Impact factor: 15.470

Review 2.  Clinical development of fenretinide as an antineoplastic drug: Pharmacology perspectives.

Authors:  Jason P Cooper; C Patrick Reynolds; Hwangeui Cho; Min H Kang
Journal:  Exp Biol Med (Maywood)       Date:  2017-04-21

3.  The use of animal models for cancer chemoprevention drug development.

Authors:  Vernon E Steele; Ronald A Lubet
Journal:  Semin Oncol       Date:  2010-08       Impact factor: 4.929

4.  Transcriptome profiling and genome-wide DNA binding define the differential role of fenretinide and all-trans RA in regulating the death and survival of human hepatocellular carcinoma Huh7 cells.

Authors:  Ying Hu; Hui-Xin Liu; Yuqi He; Yaping Fang; Jianwen Fang; Yu-Jui Yvonne Wan
Journal:  Biochem Pharmacol       Date:  2013-02-08       Impact factor: 5.858

5.  Cutaneous papilloma and squamous cell carcinoma therapy utilizing nanosecond pulsed electric fields (nsPEF).

Authors:  Dong Yin; Wangrong G Yang; Jack Weissberg; Catherine B Goff; Weikai Chen; Yoshio Kuwayama; Amanda Leiter; Hongtao Xing; Antonie Meixel; Daria Gaut; Fikret Kirkbir; David Sawcer; P Thomas Vernier; Jonathan W Said; Martin A Gundersen; H Phillip Koeffler
Journal:  PLoS One       Date:  2012-08-28       Impact factor: 3.240

6.  All trans-retinoic acid (ATRA) induces re-differentiation of early transformed breast epithelial cells.

Authors:  Maria F Arisi; Rebecca A Starker; Sankar Addya; Yong Huang; Sandra V Fernandez
Journal:  Int J Oncol       Date:  2014-03-21       Impact factor: 5.650

Review 7.  Vitamin A, cancer treatment and prevention: the new role of cellular retinol binding proteins.

Authors:  Elena Doldo; Gaetana Costanza; Sara Agostinelli; Chiara Tarquini; Amedeo Ferlosio; Gaetano Arcuri; Daniela Passeri; Maria Giovanna Scioli; Augusto Orlandi
Journal:  Biomed Res Int       Date:  2015-03-24       Impact factor: 3.411

Review 8.  Chemically induced skin carcinogenesis: Updates in experimental models (Review).

Authors:  Monica Neagu; Constantin Caruntu; Carolina Constantin; Daniel Boda; Sabina Zurac; Demetrios A Spandidos; Aristidis M Tsatsakis
Journal:  Oncol Rep       Date:  2016-03-17       Impact factor: 3.906

9.  Flow Cytometric Analysis of 4-HPR-induced Apoptosis and Cell Cycle Arrest in Acute Myelocytic Leukemia Cell Line (NB-4).

Authors:  Shahrzad Soleymani Fard; Mahmood Jeddi-Tehrani; Mohammad Mehdi Akhondi; Mehrdad Hashemi; Ali M Ardekani
Journal:  Avicenna J Med Biotechnol       Date:  2010-01
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.